BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.
about
Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemBarrett's esophagus in 2016: From pathophysiology to treatmentPost-ablation surveillance in Barrett's esophagus: A review of the literatureBarrett's esophagus: lessons from recent clinical trialsPerformance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative.Localization of specialized intestinal metaplasia and the molecular alterations in Barrett esophagus in a Japanese population: an analysis of biopsy samples based on the "Seattle" biopsy protocol.Meta-analysis of biomarkers predicting risk of malignant progression in Barrett's oesophagus.Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.Low risk of adenocarcinoma and high-grade dysplasia in patients with non-dysplastic Barrett's esophagus: Results from a cohort from a country with low esophageal adenocarcinoma incidence.Updated Guidelines for Diagnosing and Managing Barrett EsophagusProgression of Barrett's esophagus toward esophageal adenocarcinoma: an overviewCEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer.Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma.Endoscopic modalities for the diagnosis of Barrett's oesophagus.Endoluminal therapies for Barrett's esophagus.Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.Enhancing High Value Care in Gastroenterology Practice.What Makes an Expert Barrett's Histopathologist?Recurrence of Barrett's Esophagus is Rare Following Endoscopic Eradication Therapy Coupled With Effective Reflux Control.Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.Prevalence and Predictors of Gastroesophageal Reflux Complications in Community Subjects.Risk prediction in Barrett's esophagus - aspects of a combination of molecular and epidemiologic biomarkers reflecting alterations of the microenvironment.Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study.Using clinical signs of neglect to identify elder neglect cases.Response to Feuerstein J et al. "Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus". doi:10.1007/s10620-016-4222-2.Circular stripes were more common in Barrett's esophagus after acetic acid staining.CEACAM 6, a novel marker for the diagnosis of Barrett's esophagus.Critical appraisal of guidelines for screening and surveillance of Barrett's esophagusEsomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
P2860
Q26748510-50F45A18-E16D-4E75-8FAB-712F4021F38BQ26751171-FE5D267B-4CB6-4704-B4A2-7CBAC0A95321Q26751330-32D37423-C6D1-4E1A-966C-44CD90B60582Q28077141-3396C87B-83B5-4C2E-8B4C-B55A57143836Q28080253-AA01D3B0-4F1B-42FC-B862-6C923A8C13CAQ35986428-B5C25651-2466-4166-92F2-4CBD9B74A8A7Q36308513-D82EFEE3-E3C6-4E8D-B3E6-F3115226446BQ36803517-28AA4005-F37A-413D-95F8-0719577B3699Q37045741-EC8FB412-C009-4ECD-A0B6-B38252B9AC4AQ37145000-62D2CFAA-B3D2-4F87-A62A-B25C9E8D54A6Q37542809-C85341BA-B9C9-4832-B8CA-D9780D691686Q37688236-90D71BCE-3E84-4F34-AF19-CEEFEF410472Q37741832-E85ECDAE-4487-4614-9EB7-017FF897CA90Q37744606-F14259BE-CE7B-4BA8-9260-5F952B891FC2Q38670180-E7C8E201-34DE-4696-A248-60DD414C799EQ38796351-9E038AE4-C96F-4021-922A-03D7F3E6CF31Q38842110-1BDAD5B7-EAFA-494E-92DD-37AAEFC6D952Q38940516-D8BD2052-6DD7-4091-97BC-8DCB3923162EQ38962645-9A8192B4-5739-417E-94AC-2DA4827DE3E1Q38968688-D9FA4BB3-208C-4BF2-A815-6D9BFE9DEBD2Q39344023-89D9E1CC-E023-4073-A9D4-5309B3034185Q39502671-360EE69E-72D9-4D55-9255-3CA6D1C8C2F7Q39550675-55196A2D-1E93-4766-9794-3825832C771EQ47608305-E3553F30-3383-4523-8C8A-BD662186F8EAQ47731412-3DC90609-2F2A-4F8B-86DB-459E2D330D71Q48297117-EAE1240E-5943-458B-A56B-6070B61C2964Q49227541-9ACDECBA-48D0-47F0-896D-F6E2FB8BF001Q53311106-166B804A-D1C4-4116-A41D-0E36A4EA3A2EQ57177652-23A564C0-41AC-4547-9C33-67C37B7D0110Q58800614-449F8D88-555B-41B2-A665-35875494E285
P2860
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
BOB CAT: A Large-Scale Review ...... te for, or Low-Grade Dysplasia
@nl
BOB CAT: A Large-Scale Review ...... e for, or Low-Grade Dysplasia.
@ast
BOB CAT: A Large-Scale Review ...... e for, or Low-Grade Dysplasia.
@en
type
label
BOB CAT: A Large-Scale Review ...... te for, or Low-Grade Dysplasia
@nl
BOB CAT: A Large-Scale Review ...... e for, or Low-Grade Dysplasia.
@ast
BOB CAT: A Large-Scale Review ...... e for, or Low-Grade Dysplasia.
@en
prefLabel
BOB CAT: A Large-Scale Review ...... te for, or Low-Grade Dysplasia
@nl
BOB CAT: A Large-Scale Review ...... e for, or Low-Grade Dysplasia.
@ast
BOB CAT: A Large-Scale Review ...... e for, or Low-Grade Dysplasia.
@en
P2093
P2860
P50
P3181
P356
P1476
BOB CAT: A Large-Scale Review ...... e for, or Low-Grade Dysplasia.
@en
P2093
BOB CAT Consortium
David Aldulaimi
David MacDonald
David S Weinberg
Douglas A Corley
Eamonn Quigley
Giovanni Zaninotto
Hendrik Manner
Imdadur Rahman
P2860
P304
662-82; quiz 683
P3181
P356
10.1038/AJG.2015.55
P407
P50
P577
2015-04-14T00:00:00Z